Feb

    Drug Price Gouging Enforcement in US and Europe

    12 PM EST

    Steep pharmaceutical price increases are a priority for policymakers on both sides of the Atlantic. European authorities have applied antitrust prohibitions on alleged "excessive pricing” by dominant companies to impose fines over $100 million. Lacking similar US antitrust rules, certain US states, such as Maryland, have introduced pharmaceutical price transparency and anti-pricegouging laws. These provide for notification of price increases exceeding a specified threshold and empower the state to impose civil penalties and enjoin “unconscionable increases”. This panel of US and EU enforcers, including the Maryland AG's office, and practitioners examine how the laws apply in the US and EU.  

    Moderators:
    Bill Batchelor, Baker McKenzie
    Lauren Rackow, Cahill Gordon & Reindel LLP

    Speakers:
    Joshua N. Auerbach, Maryland Attorney General’s office
    Paul Csiszar, European Commission, Directorate-General for Competition
    Maria Salgado, Cornerstone, San Francisco
    Assimakis Komninos, White & Case, Brussels

    FREE:  Antitrust Section Members, Government, Non-profit Employees, Students, $25.00 Other Non-Members

    Explore Section benefits or call 1-800-285-2221 to join. Code RAT14IP25.   For this and all upcoming events visit http://ambar.org/atevents.
     
    CLE
    The ABA is not seeking CLE credit for this program.

    Audio Archive: Provided all releases are obtained, MP3 recordings of this program will be available to Section members on the Committee Program Audio page.

    $25
    NON-MEMBERS
    $10
    MEMBERS
    $0
    SECTION MEMBERS
    Register Now *Additional discounts may apply at checkout

    Log In to view your rate

    Drug Price Gouging Enforcement in US and Europe

    Event Details

    Format

    Teleconference

    Date

    Feb 12, 2018

    2018-02-12T12:00:00-05:00 2018-02-12T13:15:00-05:00 Drug Price Gouging Enforcement in US and Europe

    Steep pharmaceutical price increases are a priority for policymakers on both sides of the Atlantic. European authorities have applied antitrust prohibitions on alleged "excessive pricing” by dominant companies to impose fines over $100 million. Lacking similar US antitrust rules, certain US states, such as Maryland, have introduced pharmaceutical price transparency and anti-pricegouging laws. These provide for notification of price increases exceeding a specified threshold and empower the state to impose civil penalties and enjoin “unconscionable increases”. This panel of US and EU enforcers, including the Maryland AG's office, and practitioners examine how the laws apply in the US and EU.  

    Moderators:
    Bill Batchelor, Baker McKenzie
    Lauren Rackow, Cahill Gordon & Reindel LLP

    Speakers:
    Joshua N. Auerbach, Maryland Attorney General’s office
    Paul Csiszar, European Commission, Directorate-General for Competition
    Maria Salgado, Cornerstone, San Francisco
    Assimakis Komninos, White & Case, Brussels

    FREE:  Antitrust Section Members, Government, Non-profit Employees, Students, $25.00 Other Non-Members

    Explore Section benefits or call 1-800-285-2221 to join. Code RAT14IP25.   For this and all upcoming events visit http://ambar.org/atevents.
     
    CLE
    The ABA is not seeking CLE credit for this program.

    Audio Archive: Provided all releases are obtained, MP3 recordings of this program will be available to Section members on the Committee Program Audio page.

    Speakers

    Joshua Auerbach

    Office of the Attorney General

    Paul Csiszar

    European Commission

    Sponsors

    Health Care and Pharmaceuticals Committee

    Section of Antitrust Law

    Co-sponsors

    Section of International Law

    Moderators

    Related Products

    Related On-Demand CLE